TradingView
GregFolin
Jun 8, 2021 3:15 PM
$BIIB Launches on aducanumab Approval
NASDAQ:BIIB
1D
Biogen Inc.
NASDAQ
Description
⋅
Jun 8, 2021 3:15 PM
BIIB blasted through long-term resistance on the huge news of the company's approval for a first-of-its-kind Alzheimer's treatment. This is a multi-billion-dollar market with effectively no competition.
Chart Patterns
Technical Indicators
Beyond Technical Analysis
BIIB
More